TITAN PHARMACEUTICALS INC (TTNP.OB) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 36 transactions totaling $1.9M, demonstrating a bullish sentiment with $463.4K in net insider flow. The most recent transaction on Sep 21, 2018 involved a purchase of 80,000 shares valued at $20.0K.
No significant insider buying has been recorded for TTNP.OB in the recent period.
No significant insider selling has been recorded for TTNP.OB in the recent period.
Based on recent SEC filings, insider sentiment for TTNP.OB is bullish with an Insider Alignment Score of 62/100 and a net flow of $463.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at TITAN PHARMACEUTICALS INC (TTNP.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading TTNP.OB stock, having executed 36 transactions in the past 90 days. The most active insider is Joachim Friedrich Kapp (Executive), who has made 14 transactions totaling $1.5M.
Get notified when executives and directors at TTNP.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 21, 2018 | David Macfarlane M. | Executive | Purchase | 80,000 | $0.25 | $20.0K | |
| Jul 19, 2016 | A. Akers Joseph | Executive | Purchase | 5,000 | $4.68 | $23.4K | |
| Jul 18, 2016 | A. Akers Joseph | Executive | Purchase | 8,000 | $4.95 | $39.6K | |
| Jan 11, 2016 | Bhonsle Sunil | Executive | Purchase | 17,000 | $3.18 | $54.1K | |
| Oct 1, 2015 | Bhonsle Sunil | Executive | Purchase | 200 | $3.99 | $798 | |
| Sep 30, 2015 | Bhonsle Sunil | Executive | Purchase | 500 | $3.98 | $2.0K | |
| Sep 28, 2015 | Bhonsle Sunil | Executive | Purchase | 910 | $3.62 | $3.3K | |
| Sep 16, 2015 | Bhonsle Sunil | Executive | Purchase | 5,000 | $0.70 | $3.5K | |
| Sep 15, 2015 | Bhonsle Sunil | Executive | Purchase | 5,000 | $0.69 | $3.5K | |
| Aug 25, 2015 | Bhonsle Sunil | Executive | Purchase | 50,000 | $0.70 | $35.0K | |
| Oct 13, 2014 | Bhonsle Sunil | Executive | Purchase | 92,000 | $0.47 | $43.2K | |
| Oct 10, 2014 | Bhonsle Sunil | Executive | Purchase | 24,000 | $0.49 | $11.8K | |
| Oct 9, 2014 | Bhonsle Sunil | Executive | Purchase | 100,000 | $0.48 | $48.0K | |
| Oct 9, 2014 | Rubin Marc | Executive | Purchase | 100,000 | $0.48 | $48.0K | |
| Feb 12, 2014 | Rubin Marc | Executive | Award | 100,000 | $0.66 | $66.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 25 | $1.2M | 55.0% |
Sale(S) | 7 | $740.5K | 33.8% |
Award(A) | 2 | $132.0K | 6.0% |
Exercise(M) | 2 | $112.5K | 5.1% |
Insiders at TITAN PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 6 insiders making 36 transactions totaling $1.2M in purchases versus $740.5K in sales, the net buying activity of $463.4K signals strong executive confidence. Joachim Friedrich Kapp (Executive) leads the buying activity with $1.5M in transactions across all time.